Viewing Study NCT00004934


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2026-02-09 @ 1:08 AM
Study NCT ID: NCT00004934
Status: COMPLETED
Last Update Posted: 2013-02-04
First Post: 2000-03-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Sponsor: Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fallopian Tube Cancer View
None Ovarian Cancer View
None Primary Peritoneal Cavity Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage II ovarian epithelial cancer View
None stage III ovarian epithelial cancer View
None stage IV ovarian epithelial cancer View
None fallopian tube cancer View
None primary peritoneal cavity cancer View